LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 30.64 | 17.25 | 2182 | 1887 | 1.1561 | 1.0433 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 32.61 | 17.25 | 2179 | 2136 | 1.0200 | 1.0057 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 32.61 | 17.25 | 2245 | 2136 | 1.0509 | 1.0143 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 32.61 | 17.25 | 1259 | 2136 | 0.5893 | 0.8535 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 32.61 | 17.25 | 2432 | 2136 | 1.1384 | 1.0376 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 34.57 | 17.25 | 2419 | 2523 | 0.9587 | 0.9883 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 34.57 | 17.25 | 2478 | 2523 | 0.9821 | 0.9950 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 34.57 | 17.25 | 1852 | 2523 | 0.7340 | 0.9158 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 34.57 | 17.25 | 2635 | 2523 | 1.0443 | 1.0121 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 36.54 | 17.25 | 2620 | 2679 | 0.9777 | 0.9938 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 36.54 | 17.25 | 2689 | 2679 | 1.0034 | 1.0009 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 36.54 | 17.25 | 2278 | 2679 | 0.8501 | 0.9559 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 36.54 | 17.25 | 2854 | 2679 | 1.0650 | 1.0174 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 38.51 | 17.25 | 2865 | 2906 | 0.9859 | 0.9962 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 38.51 | 17.25 | 2934 | 2906 | 1.0096 | 1.0026 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 38.51 | 17.25 | 2215 | 2906 | 0.7622 | 0.9279 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 38.51 | 17.25 | 3067 | 2906 | 1.0554 | 1.0146 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 40.48 | 17.25 | 2722 | 3125 | 0.8708 | 0.9635 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 40.48 | 17.25 | 3258 | 3125 | 1.0423 | 1.0111 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 40.48 | 17.25 | 2727 | 3125 | 0.8724 | 0.9639 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 40.48 | 17.25 | 3414 | 3125 | 1.0922 | 1.0237 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 42.45 | 17.25 | 3454 | 3504 | 0.9857 | 0.9963 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 42.45 | 17.25 | 3591 | 3504 | 1.0248 | 1.0064 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 42.45 | 17.25 | 2879 | 3504 | 0.8216 | 0.9494 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 42.45 | 17.25 | 3739 | 3504 | 1.0670 | 1.0170 | MN20160310_N02 | F06 |